119 Results for "

Aurora B

" in MedChemExpress (MCE) Product Catalog:
Products (119)

119 Results for "Aurora B" in MCE Product Catalog:

25
25 Publications Verification
Cat. No.: HY-10127
CAS No.: 722543-31-9
Purity:  99.62%
Synonyms: AZD1152
Target:  

Aurora Kinase Apoptosis

Research Areas:  

Cancer

Barasertib (AZD1152), a pro-drug of Barasertib-hQPA, is a highly selective Aurora B inhibitor with an IC50 of 0.37 nM in a cell-free assay. Barasertib (AZD1152) induces growth arrest and apoptosis in cancer cells .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-B0712B
CAS No.: 74578-69-1
Synonyms: Ro 13-9904
Ceftriaxone sodium salt (Ro 13-9904) is a broad spectrum β-lactam third-generation cephalosporin antibiotic, which has good antibacterial activity against a variety of gram-negative and positive bacteria. Ceftriaxone sodium salt is a covalent inhibitor of GSK3β with IC50 value of 0.78 μM. Ceftriaxone sodium salt is an inhibitor of Aurora B. Ceftriaxone sodium salt has anti-inflammatory, antitumor and antioxidant activities. Ceftriaxone sodium salt can be used in the study of bacterial infections and meningitis .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-B0712
CAS No.: 73384-59-5
Synonyms: Ro 13-9904 free acid
Ceftriaxone (Ro 13-9904 free acid) is a broad spectrum β-lactam third-generation cephalosporin antibiotic, which has good antibacterial activity against a variety of gram-negative and positive bacteria. Ceftriaxone is a covalent inhibitor of GSK3β with IC50 value of 0.78 μM. Ceftriaxone is an inhibitor of Aurora B. Ceftriaxone has anti-inflammatory, antitumor and antioxidant activities. Ceftriaxone can be used in the study of bacterial infections and meningitis .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-B0712A
CAS No.: 104376-79-6
Synonyms: Ro 13-9904 sodium hydrate
Research Areas:  

Infection Cancer

Ceftriaxone sodium hydrate (Ro 13-9904 sodium hydrate) is a broad spectrum β-lactam third-generation cephalosporin antibiotic, which has good antibacterial activity against a variety of gram-negative and positive bacteria. Ceftriaxone sodium hydrate is a covalent inhibitor of GSK3β with IC50 value of 0.78 μM. Ceftriaxone sodium hydrate is an inhibitor of Aurora B. Ceftriaxone sodium hydrate has anti-inflammatory, antitumor and antioxidant activities. Ceftriaxone sodium hydrate can be used in the study of bacterial infections and meningitis .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-10161
CAS No.: 639089-54-6
Purity:  99.92%
Synonyms: VX 680; MK-0457
Target:  

Aurora Kinase Autophagy

Research Areas:  

Cancer

Tozasertib (VX 680; MK-0457) is an inhibitor of Aurora A/B/C kinases with Kis of 0.6, 18, 4.6 nM, respectively.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-14711
CAS No.: 656820-32-5
Purity:  99.22%
Target:  

Aurora Kinase Autophagy

Research Areas:  

Cancer

Reversine is a novel class of ATP-competitive Aurora kinase inhibitor with IC50s of 400, 500 and 400 nM for Aurora A, Aurora B and Aurora C, respectively.
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-12054
CAS No.: 422513-13-1
Purity:  98.89%
Research Areas:  

Cancer

Hesperadin is an ATP competitive indolinone inhibitor of Aurora A and B. Hesperadin inhibits Aurora B with an IC50 of 250 nM. Hesperadin inhibits the growth of Trypanosoma brucei by blocking nuclear division and cytokinesis. Hesperadin also is a broad-spectrum influenza antiviral .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-10126
CAS No.: 722544-51-6
Purity:  99.47%
Synonyms: AZD2811; INH-34; AZD1152-HQPA
Target:  

Aurora Kinase Apoptosis

Research Areas:  

Cancer

Barasertib-HQPA (AZD2811) is a highly selective Aurora B inhibitor with an IC50 of 0.37 nM in a cell-free assay. Barasertib-HQPA (AZD2811) induces growth arrest and apoptosis in cancer cells .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-50514
CAS No.: 896466-04-9
Research Areas:  

Cancer

AT9283 is a multi-targeted kinase inhibitor with potent activity against Aurora A/B, JAK2/3, Abl (T315I) and Flt3 (IC50s ranging from 1 to 30 nM). AT9283 inhibits growth and survival of multiple solid tumors in vitro and in vivo .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-10179
CAS No.: 827318-97-8
Purity:  99.44%
Synonyms: PHA-739358
Target:  

Aurora Kinase Autophagy

Research Areas:  

Cancer

Danusertib is a pyrrolo-pyrazole and aurora kinase inhibitor with IC50 of 13, 79, and 61 nM for Aurora A, B, and C, respectively.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-10128
CAS No.: 331771-20-1
Purity:  98.94%
Target:  

Aurora Kinase Apoptosis

Research Areas:  

Cancer

ZM-447439 is an aurora kinase inhibitor with IC50s of 110 and 130 nM for aurora A and B, respectively.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-70044
CAS No.: 942918-07-2
Synonyms: GSK-1070916A
Target:  

Aurora Kinase Apoptosis

Research Areas:  

Cancer

GSK-1070916 is a potent and selective ATP-competitive inhibitor of aurora B and aurora C with Kis of 0.38 and 1.5 nM, respectively, and is >250- fold selective over Aurora A.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-12201
CAS No.: 934541-31-8
Purity:  99.84%
Target:  

Aurora Kinase

Research Areas:  

Cancer

TAK-901 is a multi-targeted aurora inhibitor with IC50s of 21 and 15 nM for aurora A and B, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10329
CAS No.: 443797-96-4
Purity:  99.91%
Research Areas:  

Cancer

JNJ-7706621 is a potent aurora kinase inhibitor, and also inhibits CDK1 and CDK2, with IC50s of 9 nM, 3 nM, 11 nM, and 15 nM for CDK1, CDK2, aurora-A and aurora-B, respectively .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13253
CAS No.: 945595-80-2
Purity:  98.82%
Target:  

Aurora Kinase

Research Areas:  

Cancer

AMG 900 is a potent and highly selective pan-Aurora kinases inhibitor with IC50 of 5 nM, 4 nM and 1 nM for Aurora A, B and C, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10558
CAS No.: 693228-63-6
Purity:  99.03%
Target:  

Aurora Kinase

Research Areas:  

Cancer

CYC-116 is a potent aurora A and aurora B inhibitor with Kis of 8 and 9 nM, respectively.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12003
CAS No.: 1146618-41-8
Purity:  99.53%
Target:  

Aurora Kinase

Research Areas:  

Cancer

SNS-314 mesylate is a potent and selective aurora kinase inhibitor with IC50s of 9, 31, and 6 nM for aurora A, B and C, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-141512
CAS No.: 2705844-82-0
Purity:  98.97%
Target:  

PROTACs Aurora Kinase

Research Areas:  

Cancer

JB170 is a potent and highly specific PROTAC-mediated AURORA-A (Aurora Kinase) degrader (DC50=28 nM) by linking Alisertib, to the Cereblon-binding molecule Thalidomide. JB170 preferentially binds AURORA-A (EC50=193 nM) over AURORA-B (EC50=1.4 µM). JB170-mediated S-phase arrest is caused specifically by AURORA-A depletion. JB170 has excellent ability to inhibit non-catalytic function of AURORA-A kinase .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15196
CAS No.: 871026-44-7
Purity:  99.70%
Target:  

EGFR

Research Areas:  

Cancer

TAK-285 is a potent, selective, ATP-competitive and orally active HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM, respectively. TAK-285 is >10-fold selectivity for HER1/2 than HER4, and less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc. TAK-285 has effective antitumor activity . TAK-285 can cross the blood-brain barrier (BBB) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-14574
CAS No.: 942487-16-3
Purity:  99.45%
Target:  

Aurora Kinase VEGFR

Research Areas:  

Cancer

PF-03814735 is a potent, orally available, ATP-competitive and reversible aurora A and aurora B inhibitor with IC50s of 0.8 and 0.5 nM, respectively.
loading...
    loading...